FamiCord Past Earnings Performance
Past criteria checks 0/6
FamiCord's earnings have been declining at an average annual rate of -1.5%, while the Healthcare industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 22.3% per year.
Key information
-1.55%
Earnings growth rate
3.07%
EPS growth rate
| Healthcare Industry Growth | 15.67% |
| Revenue growth rate | 22.35% |
| Return on equity | -106.40% |
| Net Margin | -5.20% |
| Next Earnings Update | 28 Aug 2026 |
Recent past performance updates
Recent updates
V3V: Higher Discount Rate Will Still Support Bullish 2026 Revenue Outlook
Analysts have revised their FamiCord price target lower to €6.50 from €7.50, citing updated assumptions for revenue growth, profit margins, discount rate and future P/E that together point to a more conservative valuation framework. What's in the News for FamiCord FamiCord confirmed earnings guidance for 2026, with the Management Board expecting revenues in a range of €80 million to €90 million.Is FamiCord (ETR:V3V) Using Debt In A Risky Way?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...FamiCord AG (ETR:V3V) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
FamiCord AG ( ETR:V3V ) shares have had a really impressive month, gaining 28% after a shaky period beforehand. Looking...Is FamiCord (ETR:V3V) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Subdued Growth No Barrier To FamiCord AG (ETR:V3V) With Shares Advancing 33%
Despite an already strong run, FamiCord AG ( ETR:V3V ) shares have been powering on, with a gain of 33% in the last...FamiCord AG (ETR:V3V) Stocks Shoot Up 26% But Its P/S Still Looks Reasonable
FamiCord AG ( ETR:V3V ) shares have continued their recent momentum with a 26% gain in the last month alone. Taking a...Why We're Not Concerned About VITA 34 AG's (ETR:V3V) Share Price
When close to half the companies in the Healthcare industry in Germany have price-to-sales ratios (or "P/S") below...Revenues Tell The Story For VITA 34 AG (ETR:V3V) As Its Stock Soars 26%
VITA 34 AG ( ETR:V3V ) shareholders would be excited to see that the share price has had a great month, posting a 26...Is VITA 34 (ETR:V3V) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?
VITA 34 AG ( ETR:V3V ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the...VITA 34 AG's (ETR:V3V) CEO Compensation Looks Acceptable To Us And Here's Why
Despite strong share price growth of 39% for VITA 34 AG ( ETR:V3V ) over the last few years, earnings growth has been...Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?
While VITA 34 AG ( ETR:V3V ) might not be the most widely known stock at the moment, it saw a significant share price...Earnings Miss: VITA 34 AG Missed EPS By 29% And Analysts Are Revising Their Forecasts
VITA 34 AG ( ETR:V3V ) missed earnings with its latest full-year results, disappointing overly-optimistic forecasters...VITA 34 AG's (ETR:V3V) Intrinsic Value Is Potentially 56% Above Its Share Price
How far off is VITA 34 AG ( ETR:V3V ) from its intrinsic value? Using the most recent financial data, we'll take a look...Should You Be Adding VITA 34 (ETR:V3V) To Your Watchlist Today?
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...Here's Why VITA 34 (ETR:V3V) Can Manage Its Debt Responsibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?
VITA 34 AG ( ETR:V3V ), might not be a large cap stock, but it led the XTRA gainers with a relatively large price hike...Can Mixed Financials Have A Negative Impact on VITA 34 AG's 's (ETR:V3V) Current Price Momentum?
Most readers would already know that VITA 34's (ETR:V3V) stock increased by 4.5% over the past month. However, we...Did You Participate In Any Of VITA 34's (ETR:V3V) Fantastic 201% Return ?
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...How Is VITA 34's (ETR:V3V) CEO Compensated?
This article will reflect on the compensation paid to Wolfgang Knirsch who has served as CEO of VITA 34 AG ( ETR:V3V...Revenue & Expenses Breakdown
How FamiCord makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 26 | 88 | -5 | 50 | 0 |
| 31 Dec 25 | 88 | -5 | 50 | 0 |
| 30 Sep 25 | 88 | -10 | 54 | 0 |
| 30 Jun 25 | 88 | -9 | 53 | 0 |
| 31 Mar 25 | 86 | -11 | 51 | 0 |
| 31 Dec 24 | 82 | -11 | 47 | 0 |
| 30 Sep 24 | 81 | 4 | 31 | 0 |
| 30 Jun 24 | 79 | 1 | 32 | 0 |
| 31 Mar 24 | 78 | 0 | 33 | 0 |
| 31 Dec 23 | 77 | -2 | 32 | 0 |
| 30 Sep 23 | 75 | -25 | 33 | 0 |
| 30 Jun 23 | 73 | -24 | 32 | 0 |
| 31 Mar 23 | 71 | -27 | 32 | 0 |
| 31 Dec 22 | 69 | -27 | 32 | 0 |
| 30 Sep 22 | 63 | -12 | 29 | 0 |
| 30 Jun 22 | 50 | -11 | 24 | 0 |
| 31 Mar 22 | 39 | -6 | 18 | 0 |
| 31 Dec 21 | 28 | -4 | 13 | 0 |
| 30 Sep 21 | 21 | 0 | 10 | 0 |
| 30 Jun 21 | 21 | 0 | 9 | 0 |
| 31 Mar 21 | 20 | 1 | 9 | 0 |
| 31 Dec 20 | 20 | 1 | 9 | 0 |
| 30 Sep 20 | 20 | 1 | 9 | 0 |
| 30 Jun 20 | 20 | 1 | 9 | 0 |
| 31 Mar 20 | 20 | 1 | 10 | 0 |
| 31 Dec 19 | 20 | 1 | 10 | 0 |
| 30 Sep 19 | 20 | 1 | 9 | 0 |
| 30 Jun 19 | 20 | 1 | 9 | 0 |
| 31 Mar 19 | 20 | 1 | 10 | 0 |
| 31 Dec 18 | 20 | 1 | 10 | 0 |
| 30 Sep 18 | 21 | 2 | 10 | 0 |
| 30 Jun 18 | 21 | 1 | 11 | 0 |
| 31 Mar 18 | 20 | 0 | 11 | 0 |
| 31 Dec 17 | 19 | 0 | 10 | 0 |
| 30 Sep 17 | 18 | -1 | 10 | 0 |
| 30 Jun 17 | 16 | -1 | 10 | 0 |
| 31 Mar 17 | 17 | 1 | 9 | 0 |
| 31 Dec 16 | 16 | 0 | 9 | 0 |
| 30 Sep 16 | 16 | 2 | 10 | 0 |
| 30 Jun 16 | 16 | 2 | 9 | 0 |
| 31 Mar 16 | 15 | 2 | 9 | 0 |
| 31 Dec 15 | 14 | 2 | 9 | 0 |
| 30 Sep 15 | 14 | 1 | 8 | 0 |
Quality Earnings: V3V is currently unprofitable.
Growing Profit Margin: V3V is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: V3V is unprofitable, and losses have increased over the past 5 years at a rate of 1.5% per year.
Accelerating Growth: Unable to compare V3V's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: V3V is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (16.5%).
Return on Equity
High ROE: V3V has a negative Return on Equity (-106.4%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/27 06:31 |
| End of Day Share Price | 2026/07/24 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
FamiCord AG is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Emily Haines | First Berlin Equity Research GmbH |
| Tim Kruse | Montega AG |
| Ulrich Huwald | Warburg Research GmbH |